Vitale, D. L., Caon, I., Parnigoni, A., Sevic, I., Spinelli, F. M., Icardi, A., . . . 0000-0001-5593-9101. (2023). Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells.
Cita Chicago Style (17a ed.)Vitale, Daiana Luján, et al. Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells. 2023.
Cita MLA (8a ed.)Vitale, Daiana Luján, et al. Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells. 2023.